Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Lambeth, United Kingdom Clinical Trials

A listing of Lambeth, United Kingdom clinical trials actively recruiting patients volunteers.

RESULTS

Found (13) clinical trials

TAK-954 in Critically Ill Participants With Enteral Feeding Intolerance (EFI)

The drug being tested in this study is called TAK-954. The study will assess the treatment effect of intravenous TAK-954 in improving average daily protein adequacy received through enteral nutrition in critically ill participants with EFI. The study will enroll approximately 200 participants. Participants will be randomly assigned (by chance, ...

Phase

1.53 miles

Learn More »

Social Information Processing in Adolescents With Eating Disorders

The aim of this study is to assess the effects of adding 10 sessions of Cognitive Bias Modification (CBM) training, and goal planning using implementation intentions, to treatment as usual for adolescents with eating disorders. It is hypothesised that at baseline, participants will demonstrate cognitive biases in their attention towards ...

Phase N/A

1.71 miles

Learn More »

Domiciliary Transcutaneous Electrical Stimulation in Obstructive Sleep Apnoea

Obstructive sleep apnoea is highly prevalent, with the obesity epidemic increasing the problem. The best treatment for uncomplicated and moderate-severe OSA remains CPAP therapy. However, long-term adherence to treatment with CPAP is poor and there are few alternatives. Electrical stimulation of the dilator muscles of the upper airway has been ...

Phase N/A

2.82 miles

Learn More »

Study to Evaluate the QT / QTc Interval Prolongation Potential of Vericiguat

The objective of this study is to evaluate the effect of multiple doses of vericiguat on the QTc interval in patients with stable CAD (coronary artery disease).

Phase

2.96 miles

Learn More »

The Role of Ixazomib in Autologous Stem Cell Transplant in Relapsed Myeloma - Myeloma XII (ACCoRd)

Study design: Randomised, controlled, multi-centre, open-label, phase III trial (with a single intervention registration phase). Primary Objectives The primary objectives of this study are to determine: The impact on Depth of Response (DoR: less than VGPR versus VGPR or better) when salvage ASCT conditioning is augmented by the addition of ...

Phase

3.17 miles

Learn More »

Non-Interventional Study on the Tolerability and Efficacy of IVIG

A Non-Interventional Study on the Tolerability and Efficacy of Octagam 5% or 10% or panzyga. Patients with any indication (replacement and immonomodulation) as prescribed by the treating physician. Marketed Octagam 5% or 10% or panzyga will be used according to the investigator prescription; intravenous (iv) administration.The primary objective is to ...

Phase N/A

3.47 miles

Learn More »

Type 1 Diabetes Immunology Genetics & Endogenous Insulin Production

Background & Introduction: Type 1 Diabetes (T1D) is a disease caused by the autoimmune destruction of pancreatic beta cells. It commonly presents in childhood with elevated blood sugars and long-term insulin treatment is required. People diagnosed with T1D have some pancreatic beta cells remaining at diagnosis and these remaining insulin ...

Phase N/A

3.59 miles

Learn More »

Evaluation of CTCA in Assessing Plaque Pathology and Physiology

Cumulative evidence has demonstrated that plaque characteristics and vessel physiology are able to detect vulnerable plaques and identify high-risk individuals that are likely to suffer a cardiovascular event. The in vivo assessment of plaque morphology was traditionally performed using intravascular imaging techniques; however these modalities have significant limitations as: 1) ...

Phase N/A

4.24 miles

Learn More »

Research Into Antipsychotic Discontinuation and Reduction

Who can participate? Adults who have been diagnosed with schizophrenia, psychosis or a similar condition and are taking antipsychotic medication. What does the study involve? Once a person agrees to take part, they are randomly selected to receive either the 'antipsychotic reduction programme' or 'maintenance treatment'. The 'antipsychotic reduction programme' ...

Phase

4.67 miles

Learn More »

A First-In-Human Study of Orally Administered JNJ-64417184 to Evaluate the Safety Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses and the Antiviral Activity of Multiple Doses in a Respiratory Syncytial Virus (RSV) Challenge Study in Healthy Participants

The purpose of the study is to evaluate the safety and tolerability of single and multiple oral doses of JNJ-64417184 administered to healthy participants and the antiviral effect of multiple oral doses of JNJ-64417184 compared to placebo in participants infected through inoculation with respiratory syncytial virus (RSV)-A Memphis 37b (Part ...

Phase

4.83 miles

Learn More »